News


November 20, 2018

Avista Pharma Solutions to be Acquired by Cambrex for $252 Million

November 19, 2018

Ampersand Capital Partners Acquires Pacific Biomarkers and Merges Company with NEOMED-LABS

November 5, 2018

Detector Technology Acquires ETP Ion Detect

September 26, 2018

Brammer Bio announces progress on $200 million program to advance gene therapies

September 26, 2018

GENEWIZ to be Acquired by Brooks Automation for $450 Million

September 4, 2018

Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine

September 4, 2018

Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute

August 9, 2018

Key Biologics and Astarte Biologics Merge

June 14, 2018

Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with Brammer Bio to Support Gene Therapy Development and Commercial Supply

June 4, 2018

MolecularMD and Genoptix Enter into a Definitive Agreement to Market the MRDx® BCR-ABL Test, a Companion Diagnostic for Treatment-free Remission in Ph+ CML-CP Patients Treated with Tasigna®